RCEL - AVITA Medical: Green Shoots Peaking Out From Hard Clay
2025-08-26 08:03:18 ET
This is my sixth article on regenerative medicine and wound care company AVITA Medical ( RCEL ); it follows most recently 03/2023's AVITA Medical: At A Crossroads ". In Crossroads, I rated Avita as a "Hold". In the interim its price has ebbed and flowed, albeit the downdrafts have predominated as reflected by its ~65% overall loss since Crossroads was published....
AVITA Medical: Green Shoots Peaking Out From Hard Clay